{"id":5086,"date":"2025-08-08T15:01:43","date_gmt":"2025-08-08T08:01:43","guid":{"rendered":"https:\/\/gdhealth.vn\/?p=5086"},"modified":"2025-12-24T11:13:59","modified_gmt":"2025-12-24T04:13:59","slug":"trichomoniasis-overview","status":"publish","type":"post","link":"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/","title":{"rendered":"Trichomoniasis Overview"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_75 ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">N\u1ed9i dung trang<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#1_Introduction_to_Trichomoniasis\" >1. Introduction to Trichomoniasis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#11_What_is_Trichomonas_vaginalis\" >1.1. What is\u00a0Trichomonas vaginalis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#12_Prevalence_and_Global_Impact\" >1.2. Prevalence and Global Impact<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#13_Transmission_Methods_and_Non-Sexual_Routes\" >1.3. Transmission Methods and Non-Sexual Routes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#14_High-Risk_Populations\" >1.4. High-Risk Populations<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#2_Signs_and_Symptoms_of_Trichomonas_Infection\" >2. Signs and Symptoms of Trichomonas Infection<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#21_Symptoms_in_Women\" >2.1. Symptoms in Women<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#22_Symptoms_in_Men\" >2.2. Symptoms in Men<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#23_Asymptomatic_Status_and_the_Importance_of_Testing\" >2.3. Asymptomatic Status and the Importance of Testing<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#3_Consequences_and_Complications_of_Trichomonas_Infection\" >3. Consequences and Complications of Trichomonas Infection<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#31_Impact_on_Reproductive_Health_Vaginitis_Cervicitis_Pelvic_Inflammatory_Disease_PID_and_Infertility\" >3.1. Impact on Reproductive Health: Vaginitis, Cervicitis, Pelvic Inflammatory Disease (PID), and Infertility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#32_Impact_on_Pregnancy_and_Newborns\" >3.2. Impact on Pregnancy and Newborns<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#33_Link_with_HIV_and_other_Sexually_Transmitted_Infections\" >3.3. Link with HIV and other Sexually Transmitted Infections<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#34_Potential_Link_with_Cancer_Cervical_and_Prostate\" >3.4. Potential Link with Cancer (Cervical and Prostate)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#4_Diagnosis_of_Trichomoniasis\" >4. Diagnosis of Trichomoniasis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#41_When_is_Trichomonas_Testing_Needed\" >4.1. When is Trichomonas Testing Needed?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#42_Modern_Testing_Methods_and_Accuracy\" >4.2. Modern Testing Methods and Accuracy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#43_Specimen_Collection_Procedures_for_Men_and_Women\" >4.3. Specimen Collection Procedures for Men and Women<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#5_Treatment_of_Trichomonas\" >5. Treatment of Trichomonas<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#51_Main_Treatment_Medications_and_Mechanism_of_Action\" >5.1. Main Treatment Medications and Mechanism of Action<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#52_Recommended_Treatment_Regimens_according_to_CDC_and_WHO_Guidelines\" >5.2. Recommended Treatment Regimens according to CDC and WHO Guidelines<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#53_Treatment_for_Pregnant_and_Breastfeeding_Women\" >5.3. Treatment for Pregnant and Breastfeeding Women<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#54_Partner_Management_to_Prevent_Reinfection\" >5.4. Partner Management to Prevent Reinfection<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#55_Managing_Cases_of_Reinfection_or_Drug_Resistance\" >5.5. Managing Cases of Reinfection or Drug Resistance<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#6_Prevention_of_Trichomonas_Infection\" >6. Prevention of Trichomonas Infection<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#61_Effective_Prevention_Measures_for_Both_Men_and_Women\" >6.1. Effective Prevention Measures for Both Men and Women<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#62_Regular_Screening_and_Sexual_Health_Counseling_for_High-Risk_Groups\" >6.2. Regular Screening and Sexual Health Counseling for High-Risk Groups<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#7_Post-Treatment_Follow-up_and_Risk_of_Reinfection\" >7. Post-Treatment Follow-up and Risk of Reinfection<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#71_Follow-up_Schedule_and_Retesting\" >7.1. Follow-up Schedule and Retesting<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#72_Factors_that_Increase_the_Risk_of_Reinfection\" >7.2. Factors that Increase the Risk of Reinfection<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#8_Co-infection_and_Differential_Diagnosis\" >8. Co-infection and Differential Diagnosis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#81_Co-infection_with_other_STI_Agents\" >8.1. Co-infection with other STI Agents<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#82_Which_Agents_are_Trichomoniasis_Symptoms_Easily_Confused_With\" >8.2. Which Agents are Trichomoniasis Symptoms Easily Confused With?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/gdhealth.vn\/en\/trichomoniasis-overview\/#9_Conclusion\" >9. Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"1_Introduction_to_Trichomoniasis\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"0\">1. Introduction to Trichomoniasis<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"11_What_is_Trichomonas_vaginalis\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"1\">1.1. What is\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"2\">Trichomonas vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"3\">?<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"4\">Trichomoniasis is a very common sexually transmitted infection (STI), caused by a single-celled protozoan parasite named\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"5\">Trichomonas vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"6\">. It is important to note that Trichomoniasis is caused by a parasite, not a virus. It is the most common non-viral STI globally and can be completely cured with medication. Although the disease is curable, the high global prevalence of Trichomoniasis highlights significant challenges in diagnosis, access to treatment, and disease control. Therefore, Trichomoniasis is sometimes considered a &#8220;neglected parasitic disease.&#8221;<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-3320 size-medium\" src=\"https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/trung-roi-300x204.jpg\" alt=\"Trichomonas g\u00e2y vi\u00eam \u00e2m \u0111\u1ea1o\" width=\"300\" height=\"204\" srcset=\"https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/trung-roi-300x204.jpg 300w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/trung-roi-768x522.jpg 768w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/trung-roi-600x408.jpg 600w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/trung-roi.jpg 800w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"12_Prevalence_and_Global_Impact\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"7\">1.2. Prevalence and Global Impact<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"8\">Trichomoniasis is a global public health issue of significant scale. In the United States, an estimated 3.7 million people are infected. Globally, the World Health Organization (WHO) estimated approximately 156 million new\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"9\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"10\">\u00a0infections among people aged 15\u201349 in 2020, including 73.7 million cases in women and 82.6 million in men. About one-third of these new infections are concentrated in the WHO African region. Notably, the global incidence of\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"11\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"12\">\u00a0is higher than the sum of\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"13\">Chlamydia trachomatis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"14\">,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"15\">Neisseria gonorrhoeae<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"16\">, and syphilis combined.<\/span><\/p>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"17\">Disease prevalence shows significant differences among population groups. Infection is more common in women than in men, and older women have a higher risk than younger women. In the United States, the disease is also more common in Black women. These epidemiological patterns are not random; they are linked to factors such as older age, lower education levels, lower socioeconomic status, and multiple sexual partners. Studies also indicate that structural racism has contributed to maintaining this significant disparity in the Black community. Socioeconomic factors and systemic inequalities play a crucial role in determining who gets infected and who is diagnosed and treated. Therefore, prevention and control efforts must be culturally sensitive, address health equity, and focus resources on affected or higher-risk communities and individuals, rather than solely on individual sexual behavior.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"13_Transmission_Methods_and_Non-Sexual_Routes\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"18\">1.3. Transmission Methods and Non-Sexual Routes<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<h3 style=\"text-align: justify;\"><b><img decoding=\"async\" class=\"aligncenter wp-image-3557 size-large\" src=\"https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/08\/Su-lay-truyen-cua-Trichomonas-1024x683.png\" alt=\"Trichomonas (tr\u00f9ng roi \u00e2m \u0111\u1ea1o) l\u00e2y truy\u1ec1n qua \u0111\u01b0\u1eddng n\u00e0o\" width=\"1024\" height=\"683\" srcset=\"https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/08\/Su-lay-truyen-cua-Trichomonas-1024x683.png 1024w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/08\/Su-lay-truyen-cua-Trichomonas-300x200.png 300w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/08\/Su-lay-truyen-cua-Trichomonas-768x512.png 768w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/08\/Su-lay-truyen-cua-Trichomonas-600x400.png 600w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/08\/Su-lay-truyen-cua-Trichomonas.png 1536w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/b><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"19\">The parasite\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"20\">Trichomonas vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"21\">\u00a0spreads from an infected person to an uninfected person during sexual intercourse. It is primarily transmitted through genital contact, including vaginal, oral, or anal sex. The most common transmissions are from penis to vagina, vagina to penis, or vagina to vagina. Additionally, it can also spread through skin-to-skin contact in the genital area without ejaculation. Sharing sex toys without proper cleaning or not using a condom can also transmit the parasite.<\/span><\/p>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"22\">It is important to understand these transmission routes for effective prevention measures and to dispel common myths. Trichomoniasis is not spread through non-sexual contact, such as sharing food or drinks, kissing, or holding hands. Poor personal hygiene is also not a cause of Trichomoniasis, as it is a parasitic sexually transmitted disease. Although there are some rare reports suggesting potential transmission from towels, toilet seats, or swimming pools, in most cases, it is a sexually transmitted disease. Emphasizing sexual transmission while dispelling hygiene myths is critical for delivering effective public health messages. This helps shift the focus from shame or blame to understanding the actual routes of transmission, encouraging testing and treatment without stigma.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"14_High-Risk_Populations\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"23\">1.4. High-Risk Populations<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"24\">Anyone who is sexually active can contract Trichomoniasis. However, some groups have a significantly higher risk. The disease is more common in women than in men, and older women have a higher risk than younger women. In the United States, Black women also have a higher prevalence. Key risk factors that increase the likelihood of infection include: not using a condom during sexual intercourse, having multiple sexual partners, a history of other STIs, having a new partner or contact with a confirmed infected partner, intravenous drug abuse, and not using any form of barrier contraception.<\/span><\/p>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"25\">Identifying these specific high-risk groups is crucial for developing tailored public health interventions that go beyond general awareness. For example, women living with HIV are recommended for routine screening for\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"26\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"27\">. Additionally, studies have shown that sex workers are a group with a very high prevalence, at 12.16% in one specific study. Public health campaigns and clinical guidelines should prioritize these groups with targeted screening, education, and service access, as a &#8220;one-size-fits-all&#8221; strategy will not be sufficient for effective Trichomoniasis control.<\/span><\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"2_Signs_and_Symptoms_of_Trichomonas_Infection\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"28\">2. Signs and Symptoms of Trichomonas Infection<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"21_Symptoms_in_Women\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"29\">2.1. Symptoms in Women<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"30\">When a Trichomonas infection causes symptoms, they can range from mild irritation to severe inflammation. Symptoms can begin 5 to 28 days after infection, or much later, and may appear and disappear. Common symptoms in women include:<\/span><\/p>\n<ul class=\"appsElementsGenerativeaiAstList\">\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"31\">Abnormal Vaginal Discharge:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"32\">\u00a0Often thin or frothy, may be clear, white, yellow, or greenish, accompanied by an abnormal foul odor, often described as a &#8220;fishy smell.&#8221; Vaginal discharge is the main symptom women may experience, and in some cases, it may contain pus, along with vaginal redness and pain.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"33\">Genital Irritation:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"34\">\u00a0Itching, burning, redness, or pain in the genital area, including the vulva and vagina.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"35\">Discomfort during urination and sexual intercourse:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"36\">\u00a0A burning sensation or pain during urination (dysuria) and during sexual intercourse (dyspareunia).<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"37\">Lower Abdominal Pain:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"38\">\u00a0Some women may feel pain in the lower abdomen.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"39\">&#8220;Strawberry Cervix&#8221;:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"40\">\u00a0A characteristic but rare clinical sign is a &#8220;strawberry&#8221; shaped cervix (colpitis macularis), with tiny red spots on the surface. This sign only appears in about 2-5% of cases.<\/span><\/li>\n<\/ul>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"22_Symptoms_in_Men\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"41\">2.2. Symptoms in Men<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"42\">Unlike women, most men infected with Trichomoniasis do not have any symptoms. This is an important factor contributing to the spread of the disease. When symptoms do occur, they may include:<\/span><\/p>\n<ul class=\"appsElementsGenerativeaiAstList\">\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"43\">Penile Irritation:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"44\">\u00a0Itching or irritation inside the penis.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"45\">Burning sensation during urination or ejaculation:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"46\">\u00a0A burning sensation after urination or ejaculation.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"47\">Penile Discharge:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"48\">\u00a0Discharge may be clear, pus-like, or frothy.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"49\">Urethritis:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"50\">\u00a0Some men may experience urethral inflammation or urethral discharge.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"51\">Less common symptoms:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"52\">\u00a0Testicular pain, frequent urination, or cloudy urine. In some cases, Trichomoniasis can cause urethritis, epididymitis, or prostatitis.<\/span><\/li>\n<\/ul>\n<figure id=\"attachment_2745\" aria-describedby=\"caption-attachment-2745\" style=\"width: 500px\" class=\"wp-caption aligncenter\"><img decoding=\"async\" class=\"wp-image-2745\" src=\"https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/Hinh-minh-hoa-3.png\" alt=\"Tri\u1ec7u ch\u1ee9ng v\u00e0 d\u1ea5u hi\u1ec7u nh\u1eadn bi\u1ebft Trichomonas\n\" width=\"500\" height=\"567\" srcset=\"https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/Hinh-minh-hoa-3.png 867w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/Hinh-minh-hoa-3-265x300.png 265w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/Hinh-minh-hoa-3-768x871.png 768w, https:\/\/gdhealth.vn\/wp-content\/uploads\/2025\/07\/Hinh-minh-hoa-3-600x680.png 600w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/><figcaption id=\"caption-attachment-2745\" class=\"wp-caption-text\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"0\">The majority of people infected with Trichomoniasis often show no clear symptoms initially<\/span><\/figcaption><\/figure>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"23_Asymptomatic_Status_and_the_Importance_of_Testing\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"53\">2.3. Asymptomatic Status and the Importance of Testing<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"54\">One of the most challenging characteristics of Trichomoniasis is the high rate of asymptomatic cases. About 70% of infected individuals have no obvious signs or symptoms. This means many people are unaware they are infected and unintentionally transmit the parasite to others. Because symptoms are often vague or absent, Trichomoniasis cannot be diagnosed based on clinical signs alone. The absence of symptoms also allows the infection to persist for months or even years if left untreated. The high rate of asymptomatic infection is the main cause driving continuous transmission and making disease control difficult. This creates a vicious cycle where people unintentionally spread the infection, hindering effective public health control if only relying on symptom-based diagnosis. Therefore, accurate and timely diagnosis requires laboratory testing, especially for high-risk groups, even in the absence of symptoms. Thus, a proactive screening strategy and comprehensive partner treatment are extremely important to break the chain of transmission.<\/span><\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"3_Consequences_and_Complications_of_Trichomonas_Infection\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"55\">3. Consequences and Complications of Trichomonas Infection<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"56\">Untreated Trichomoniasis can lead to numerous severe consequences and complications, affecting reproductive health, pregnancy, and increasing the risk of contracting other sexually transmitted infections.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"31_Impact_on_Reproductive_Health_Vaginitis_Cervicitis_Pelvic_Inflammatory_Disease_PID_and_Infertility\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"57\">3.1. Impact on Reproductive Health: Vaginitis, Cervicitis, Pelvic Inflammatory Disease (PID), and Infertility<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"58\">In women,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"59\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"60\">\u00a0is a common cause of vaginal discharge and is associated with an increased risk of developing Pelvic Inflammatory Disease (PID). PID is a serious inflammatory condition affecting the uterus, fallopian tubes, and ovaries, which can lead to infertility, increased risk of ectopic pregnancy, and chronic pelvic pain. Trichomoniasis can also cause vaginitis, cervicitis, and urethritis in women. Vaginitis is the most common clinical manifestation in symptomatic women. Additionally,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"61\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"62\">\u00a0infection is also linked to infertility in women. Proposed mechanisms include the activation of the host&#8217;s immune system, leading to damage and inflammation of uterine and fallopian tube epithelial cells, as well as direct damage to oocytes and interference with ovulation. In men,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"63\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"64\">\u00a0infection is also associated with infertility, potentially by impairing sperm motility through binding to sperm glycoproteins, causing phagocytosis and\/or hindering the lateral movement of sperm, as well as direct damage and destruction of sperm cells.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"32_Impact_on_Pregnancy_and_Newborns\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"65\">3.2. Impact on Pregnancy and Newborns<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"66\">Trichomoniasis infection during pregnancy is a serious concern as it is associated with adverse pregnancy outcomes. Pregnant women with Trichomoniasis are more likely to have preterm birth (delivering too early) and low birth weight babies (under 2.5 kg). It is also associated with premature rupture of membranes. Although rare, the infection can be transmitted to the baby as it passes through the birth canal, leading to vaginal and respiratory infections in the newborn. The link between Trichomoniasis and adverse pregnancy outcomes like preterm birth and low birth weight emphasizes the need for screening and treatment in pregnant women. Timely diagnosis and treatment are crucial during pregnancy. Metronidazole, the primary treatment drug, is considered safe for pregnant women. However, a notable point is that current guidelines do not recommend routine screening for asymptomatic pregnant women. This indicates a potential gap in public health policy or clinical practice, where the known risks of infection during pregnancy may not be adequately addressed by universal screening. Some experts have suggested that Trichomoniasis should be a reportable condition for pregnant women screening due to these adverse pregnancy outcomes. Healthcare providers should consider individual risk factors for pregnant patients to ensure timely diagnosis and treatment.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"33_Link_with_HIV_and_other_Sexually_Transmitted_Infections\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"67\">3.3. Link with HIV and other Sexually Transmitted Infections<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"68\">Trichomoniasis infection can significantly increase the risk of contracting or transmitting other sexually transmitted infections. This parasite causes genital inflammation, creating a more favorable environment for HIV infection or transmitting the HIV virus to a partner. Increasing evidence shows that Trichomoniasis enhances HIV transmission. Conversely, people living with HIV may also have a higher risk of\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"69\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"70\">\u00a0infection. The inflammation caused by\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"71\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"72\">\u00a0acts as a biological cofactor, significantly increasing the risk of HIV acquisition and transmission. This means the infection is not just a nuisance but creates a biologically conducive environment for the spread of a much more severe STI like HIV. Therefore, treating and preventing Trichomoniasis can be a crucial strategy in the broader fight against HIV\/AIDS, especially in areas with high prevalence or in key population groups. Additionally, Trichomoniasis is strongly associated with the presence of other STIs, including\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"73\">Chlamydia trachomatis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"74\">,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"75\">Neisseria gonorrhoeae<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"76\">,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"77\">Treponella pallidum<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"78\">\u00a0(syphilis), human papillomavirus (HPV), and herpes simplex virus (HSV) types 1 and 2.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"34_Potential_Link_with_Cancer_Cervical_and_Prostate\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"79\">3.4. Potential Link with Cancer (Cervical and Prostate)<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"80\">Studies have indicated a potential link between\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"81\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"82\">\u00a0infection and the risk of certain cancers.\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"83\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"84\">\u00a0infection is associated with a higher risk of developing prostate or cervical cancer. For cervical cancer, individuals infected with\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"85\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"86\">\u00a0have a higher risk, especially when co-infected with human papillomavirus (HPV). This association is supported by meta-analyses. Proposed reasons include a higher rate of co-infection with high-risk HPV types. This suggests a possible synergistic effect where\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"87\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"88\">\u00a0creates a favorable environment for HPV infection or the progression of precancerous lesions to cancer. This finding reinforces the importance of comprehensive STI screening and management, including HPV vaccination and cervical cancer screening, as part of a holistic approach to sexual health. For men,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"89\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"90\">\u00a0infection is also associated with prostate cancer, although studies are inconclusive and remain controversial. Some studies suggest that this parasite may cause proliferation of prostatic epithelial cells and chronic inflammation. The link with cervical and prostate cancer, especially the synergistic effect with HPV for cervical cancer, suggests a more complex and serious long-term impact than previously understood for Trichomoniasis.<\/span><\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"4_Diagnosis_of_Trichomoniasis\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"91\">4. Diagnosis of Trichomoniasis<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"41_When_is_Trichomonas_Testing_Needed\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"92\">4.1. When is Trichomonas Testing Needed?<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"93\">The diagnosis of Trichomoniasis cannot rely solely on clinical symptoms, so laboratory testing is essential to confirm the infection. Testing is used to diagnose infection in symptomatic individuals. Even in the absence of clear symptoms, testing may be recommended for high-risk women, such as those who have unprotected sexual intercourse, have multiple sexual partners, or have a history of other STIs. Retesting is also recommended after completing treatment to ensure the infection has been completely eliminated and there is no reinfection. When a patient presents for examination, the healthcare provider will discuss their medical and sexual history and conduct a genital examination to look for suggestive signs. However, it should be noted that routine gynecological or urological examination often does not include identifying Trichomoniasis.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"42_Modern_Testing_Methods_and_Accuracy\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"94\">4.2. Modern Testing Methods and Accuracy<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"95\">There are several different testing methods for diagnosing\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"96\">Trichomonas vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"97\">, each with its own advantages and disadvantages in terms of sensitivity, specificity, time to results, and cost.<\/span><\/p>\n<ul class=\"appsElementsGenerativeaiAstList\">\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"98\">Wet Mount Microscopy (Soi t\u01b0\u01a1i d\u1ecbch ti\u1ebft):<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"99\">\u00a0This method has traditionally been preferred for women because it is inexpensive and can be performed on-site in the clinic. However, it has low sensitivity (44%\u201368%) compared to culture. The sensitivity of the wet mount test decreases rapidly, dropping to only about 20% within 1 hour after sample collection. This method is not suitable for men due to very low sensitivity.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"100\">Nucleic Acid Amplification Tests (NAATs):<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"101\">\u00a0NAATs have very high sensitivity (95\u2013100%) and high specificity (95\u2013100%). They are considered the gold standard in some settings for the diagnosis of\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"102\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"103\">. NAATs are approved by the U.S. Food and Drug Administration (FDA) for use in symptomatic or asymptomatic women using vaginal swab samples (collected by a clinician or self-collected), cervical swabs, urine samples, and liquid-based cervical cytology samples (liquid Pap smear). Some NAATs are also FDA-approved for male urine samples. The shift from wet mount to NAATs as the &#8220;gold standard&#8221; indicates a major improvement in diagnostic accuracy, which plays a critical role in identifying asymptomatic cases and improving public health control.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"104\">Rapid Antigen Tests (C\u00e1c x\u00e9t nghi\u1ec7m nhanh):<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"105\">\u00a0Examples include the OSOM Trichomonas Rapid Test, which can be performed on-site and provides results in 10-15 minutes. These tests have a sensitivity of 82%\u201395% and a specificity of 97%\u2013100%. However, they are mainly for women, and the OSOM test is not recommended for men due to low sensitivity (38%).<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"106\">Culture (Nu\u00f4i c\u1ea5y):<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"107\">\u00a0Previously, culture was considered the gold standard for diagnosing\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"108\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"109\">. This method has a sensitivity of 75%\u201396% but results often take 3-7 days. For women, vaginal discharge samples are preferred because urine culture is less sensitive. For men, a urethral swab, centrifuged urine sediment, or semen sample is needed.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"110\">Pap Smears (Ph\u1ebft t\u1ebf b\u00e0o c\u1ed5 t\u1eed cung):<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"111\">\u00a0Pap smears are not suitable for routine Trichomoniasis screening or diagnosis due to poor sensitivity. However, if Pap smear results suggest a possible asymptomatic infection, additional tests (wet mount, NAAT, culture, or rapid test) should be performed to confirm the diagnosis.<\/span><\/li>\n<\/ul>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"43_Specimen_Collection_Procedures_for_Men_and_Women\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"112\">4.3. Specimen Collection Procedures for Men and Women<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"113\">The specimen collection procedure for\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"114\">Trichomonas vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"115\">\u00a0testing varies depending on the gender and the type of test used:<\/span><\/p>\n<ul class=\"appsElementsGenerativeaiAstList\">\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"116\">For Women:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"117\">\u00a0Samples can be collected from vaginal discharge (by a clinician or self-collected with a swab), cervical swabs, or urine samples.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"118\">For Men:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"119\">\u00a0Samples can be collected from the urethra (with a swab), urine (first-void urine sample), or semen.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"120\">Note for Urine Sample Collection:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"121\">\u00a0To ensure accuracy, patients should not urinate for at least one hour before sample collection. Approximately 20-30 mL of first-void urine (the first part of the urine stream) should be provided in a clean container.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: center;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"0\">Table 1: Comparison of Diagnostic Methods for\u00a0<\/span><i><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"1\">Trichomonas vaginalis<\/span><\/strong><\/i><\/p>\n<table style=\"width: 100%; height: 496px;\">\n<thead>\n<tr>\n<th style=\"width: 10.8824%;\">Diagnostic Method\u00a0<\/th>\n<th style=\"width: 18.8971%;\">Sample Type\u00a0<\/th>\n<th style=\"width: 7.35294%;\">Sensitivity\u00a0<\/th>\n<th style=\"width: 7.79412%;\">Specificity\u00a0<\/th>\n<th style=\"width: 8.08824%;\">Time to Results\u00a0<\/th>\n<th style=\"width: 21.25%;\">Main Advantages\u00a0<\/th>\n<th style=\"width: 24.4853%;\">Main Disadvantages\u00a0<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"width: 10.8824%; text-align: left;\"><span data-ast-node-id=\"2\">Wet Mount Microscopy\u00a0<\/span><\/td>\n<td style=\"width: 18.8971%; text-align: left;\"><span data-ast-node-id=\"3\">Vaginal\/Urethral discharge\u00a0<\/span><\/td>\n<td style=\"width: 7.35294%; text-align: left;\"><span data-ast-node-id=\"4\">44%\u201368%<\/span><\/td>\n<td style=\"width: 7.79412%; text-align: left;\"><span data-ast-node-id=\"5\">High<\/span><\/td>\n<td style=\"width: 8.08824%; text-align: left;\"><span data-ast-node-id=\"6\">Minutes\u00a0<\/span><\/td>\n<td style=\"width: 21.25%; text-align: left;\"><span data-ast-node-id=\"7\">Quick, inexpensive, performed on-site\u00a0<\/span><\/td>\n<td style=\"width: 24.4853%; text-align: left;\"><span data-ast-node-id=\"8\">Low sensitivity, decreases quickly over time, not used for men\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 10.8824%; text-align: left;\"><span data-ast-node-id=\"9\">NAATs\u00a0<\/span><\/td>\n<td style=\"width: 18.8971%; text-align: left;\"><span data-ast-node-id=\"10\">Vaginal, Cervical discharge, Urine (male\/female)<\/span><\/td>\n<td style=\"width: 7.35294%; text-align: left;\"><span data-ast-node-id=\"11\">95%\u2013100%<\/span><\/td>\n<td style=\"width: 7.79412%; text-align: left;\"><span data-ast-node-id=\"12\">95%\u2013100%<\/span><\/td>\n<td style=\"width: 8.08824%; text-align: left;\"><span data-ast-node-id=\"13\">Hours to 1 day\u00a0<\/span><\/td>\n<td style=\"width: 21.25%; text-align: left;\"><span data-ast-node-id=\"14\">Highest sensitivity and specificity, detects asymptomatic cases\u00a0<\/span><\/td>\n<td style=\"width: 24.4853%; text-align: left;\"><span data-ast-node-id=\"15\">Higher cost, requires specialized laboratory\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 10.8824%; text-align: left;\"><span data-ast-node-id=\"16\">Rapid Antigen Tests\u00a0<\/span><\/td>\n<td style=\"width: 18.8971%; text-align: left;\"><span data-ast-node-id=\"17\">Vaginal discharge (female)\u00a0<\/span><\/td>\n<td style=\"width: 7.35294%; text-align: left;\"><span data-ast-node-id=\"18\">82%\u201395%<\/span><\/td>\n<td style=\"width: 7.79412%; text-align: left;\"><span data-ast-node-id=\"19\">97%\u2013100%<\/span><\/td>\n<td style=\"width: 8.08824%; text-align: left;\"><span data-ast-node-id=\"20\">10\u201315 minutes\u00a0<\/span><\/td>\n<td style=\"width: 21.25%; text-align: left;\"><span data-ast-node-id=\"21\">Quick, performed on-site\u00a0<\/span><\/td>\n<td style=\"width: 24.4853%; text-align: left;\"><span data-ast-node-id=\"22\">Lower sensitivity than NAATs, not used for men<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 10.8824%; text-align: left;\"><span data-ast-node-id=\"23\">Culture\u00a0<\/span><\/td>\n<td style=\"width: 18.8971%; text-align: left;\"><span data-ast-node-id=\"24\">Vaginal discharge, Urethral discharge, Urine sediment, Semen<\/span><\/td>\n<td style=\"width: 7.35294%; text-align: left;\"><span data-ast-node-id=\"25\">75%\u201396%<\/span><\/td>\n<td style=\"width: 7.79412%; text-align: left;\"><span data-ast-node-id=\"26\">Nearly 100%\u00a0<\/span><\/td>\n<td style=\"width: 8.08824%; text-align: left;\"><span data-ast-node-id=\"27\">3\u20137 days\u00a0<\/span><\/td>\n<td style=\"width: 21.25%; text-align: left;\"><span data-ast-node-id=\"28\">High specificity, was once the gold standard\u00a0<\/span><\/td>\n<td style=\"width: 24.4853%; text-align: left;\"><span data-ast-node-id=\"29\">Takes a long time, lower sensitivity than NAATs, requires special sample transport\u00a0<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"5_Treatment_of_Trichomonas\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"122\">5. Treatment of Trichomonas<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"51_Main_Treatment_Medications_and_Mechanism_of_Action\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"123\">5.1. Main Treatment Medications and Mechanism of Action<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"124\">Trichomoniasis is a disease that can be effectively treated and cured with medication. The main class of antibiotics known to be effective against\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"125\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"126\">\u00a0is nitroimidazole. The most common drugs in this group are metronidazole and tinidazole. Secnidazole is also another treatment option. These drugs work by interfering with the parasite&#8217;s DNA synthesis process, leading to their destruction.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"52_Recommended_Treatment_Regimens_according_to_CDC_and_WHO_Guidelines\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"127\">5.2. Recommended Treatment Regimens according to CDC and WHO Guidelines<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"128\">Treatment guidelines from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) recommend specific regimens for men and women:<\/span><\/p>\n<ul class=\"appsElementsGenerativeaiAstList\">\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"129\">For Women:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"130\">\u00a0The recommended regimen is Metronidazole 500 mg orally twice daily for 7 days.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"131\">For Men:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"132\">\u00a0The recommended regimen is Metronidazole 2 g orally as a single dose.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"133\">Alternative Regimen (for both men and women):<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"134\">\u00a0Tinidazole 2 g orally as a single dose. Tinidazole is often more expensive but can achieve higher concentrations in the serum and urogenital tract, has a longer half-life than metronidazole, and fewer gastrointestinal side effects.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"135\">A critical note is the avoidance of alcohol during treatment with nitroimidazoles. Traditionally, alcohol abstinence has been recommended for 24 hours after metronidazole and 72 hours after tinidazole to avoid a disulfiram-like reaction. However, recent CDC guidelines suggest that limited alcohol consumption (no more than one drink per day) may be acceptable when taking metronidazole, as direct inhibition of acetaldehyde dehydrogenase is not observed.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"53_Treatment_for_Pregnant_and_Breastfeeding_Women\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"136\">5.3. Treatment for Pregnant and Breastfeeding Women<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"137\">Treatment of Trichomoniasis during pregnancy is very important due to potential risks to the fetus. Metronidazole is considered safe for pregnant women. Pregnant patients can receive a metronidazole regimen similar to non-pregnant patients (Metronidazole 500 mg twice daily for 7 days). Although some clinicians may prefer to delay treatment until the second trimester, timely treatment is necessary once the diagnosis is confirmed. For breastfeeding women, metronidazole passes into breast milk and may affect the taste. Manufacturers recommend avoiding high doses or interrupting breastfeeding for 12-24 hours after a single dose to reduce infant exposure. Tinidazole and Secnidazole are generally not recommended for pregnant women due to a lack of adequate safety studies. Tinidazole is classified as a Category C drug in pregnancy, and the manufacturer contraindicates its use in the first trimester.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"54_Partner_Management_to_Prevent_Reinfection\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"138\">5.4. Partner Management to Prevent Reinfection<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"139\">To achieve long-term treatment effectiveness and prevent reinfection, partner management is an extremely critical factor. About 1 in 5 people become reinfected within 3 months after treatment. This usually happens if sexual intercourse occurs without a condom with an untreated partner. Therefore, to avoid reinfection, all sexual partners must be treated at the same time as the patient. Patients should abstain from sexual activity until both the patient and all partners have completed treatment and all symptoms have disappeared, usually about 7-10 days after finishing the medication course. The high rate of reinfection despite the possibility of a cure highlights the challenges in partner notification and adherence to treatment and abstinence guidelines. This emphasizes that public health efforts need to improve strategies for partner services (notification, testing, treatment), and patient counseling must strongly emphasize the importance of partner treatment and temporary abstinence to achieve a lasting cure and prevent community spread.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"55_Managing_Cases_of_Reinfection_or_Drug_Resistance\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"140\">5.5. Managing Cases of Reinfection or Drug Resistance<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"141\">In some cases, Trichomoniasis can recur or become drug-resistant, making treatment difficult. Recurrent cases may be due to non-adherence to treatment (not taking the full dose or for the full duration), reinfection from an untreated partner, or the parasite having developed resistance to metronidazole. Metronidazole resistance occurs in 4-10% of vaginal Trichomoniasis cases. If symptoms still persist after the initial therapy, these possibilities should be considered. For the first treatment failure, retreatment with metronidazole 500mg orally twice daily for 7 days is recommended. If this second treatment fails, metronidazole 2g orally once daily for 3-5 days may be used. For persistent treatment failure, expert consultation and consideration of\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"142\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"143\">\u00a0metronidazole susceptibility testing are required. The CDC provides recommendations for managing recurrent\/persistent Trichomoniasis and performing susceptibility testing for refractory cases. Tinidazole can be effective against some metronidazole-resistant strains. Other alternative regimens tested for resistant cases include high-dose metronidazole (2g daily for 7 days) or tinidazole (2g daily for 14 days along with 500mg vaginal tinidazole twice daily).<\/span><\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"6_Prevention_of_Trichomonas_Infection\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"144\">6. Prevention of Trichomonas Infection<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"61_Effective_Prevention_Measures_for_Both_Men_and_Women\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"145\">6.1. Effective Prevention Measures for Both Men and Women<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"146\">The only way to completely avoid all STIs, including Trichomoniasis, is to abstain from vaginal, anal, or oral sex. However, if sexually active, the risk of infection can be significantly reduced by adopting the following measures:<\/span><\/p>\n<ul class=\"appsElementsGenerativeaiAstList\">\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"147\">Monogamy:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"148\">\u00a0Maintain a long-term, mutually monogamous relationship with a partner who has been tested and is negative for STIs, and only have sexual intercourse with that one partner.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"149\">Correct Condom Use:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"150\">\u00a0Use a latex condom correctly every time you have sexual intercourse. It is crucial to put the condom on before the penis touches the vagina, mouth, or anus. However, it should be noted that the parasite\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"151\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"152\">\u00a0can infect skin areas not covered by the condom, so condoms may not provide complete protection in all cases. Acknowledging the incomplete protection of condoms against Trichomoniasis due to skin-to-skin contact outside the covered areas is an important nuance for informed prevention. This suggests that Trichomoniasis prevention strategies should emphasize a multifaceted approach, including monogamy, partner testing, and open communication, in addition to condom use.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"153\">Open Communication:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"154\">\u00a0Discuss potential STI risks with new partners before sexual intercourse.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"155\">Limit the Number of Partners:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"156\">\u00a0Reducing the number of sexual partners also helps reduce the risk of exposure.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"157\">Avoid Vaginal Douching:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"158\">\u00a0Do not douche the vagina, as this can eliminate the natural beneficial bacteria in the vagina, increasing the risk of infection.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"159\">Avoid Substance Abuse:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"160\">\u00a0Avoid abusing alcohol or illegal drugs, as they can impair judgment and lead to risky sexual behavior.<\/span><\/li>\n<li class=\"appsElementsGenerativeaiAstAnimated\"><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"161\">Understand Ineffective Measures:<\/span><\/strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"162\">\u00a0Washing genitals, urinating, or douching\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"163\">after<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"164\">\u00a0sexual intercourse will not prevent any STI.<\/span><\/li>\n<\/ul>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"62_Regular_Screening_and_Sexual_Health_Counseling_for_High-Risk_Groups\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"165\">6.2. Regular Screening and Sexual Health Counseling for High-Risk Groups<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"166\">Regular screening and sexual health counseling play a vital role in preventing and controlling Trichomoniasis, especially for high-risk groups. Routine testing for Trichomoniasis and other STIs is recommended. Open and honest communication with partners about sexual history and potential risks is an essential part of effective prevention. Prevention counseling should be offered to all sexually active adolescents and high-risk adults. While screening is not generally recommended for asymptomatic women, it can be considered in areas with high prevalence or for women at high risk, such as those with multiple partners, sex in exchange for money, use of illegal drugs, or a history of STIs. The CDC specifically recommends routine screening for\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"167\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"168\">\u00a0for asymptomatic people with HIV infection.<\/span><\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"7_Post-Treatment_Follow-up_and_Risk_of_Reinfection\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"169\">7. Post-Treatment Follow-up and Risk of Reinfection<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"71_Follow-up_Schedule_and_Retesting\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"170\">7.1. Follow-up Schedule and Retesting<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"171\">After completing treatment for Trichomoniasis, follow-up is necessary to ensure the infection has been completely eliminated and to prevent reinfection. For women with a positive test result for Trichomoniasis, retesting is recommended 3 months after treatment. The primary purpose of this retesting is to detect any cases of reinfection. For men, retesting is generally not necessary unless symptoms return. If any symptoms of Trichomoniasis reappear after treatment, both men and women should seek medical care again immediately for evaluation and timely treatment.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"72_Factors_that_Increase_the_Risk_of_Reinfection\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"172\">7.2. Factors that Increase the Risk of Reinfection<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"173\">Reinfection with Trichomoniasis is a common problem, with about 1 in 5 people becoming reinfected within 3 months after the initial treatment. This can happen if sexual intercourse occurs without a condom with a partner who is still infected with Trichomoniasis. Reinfection is particularly common in sexually active people. Key factors that increase the risk of reinfection include: inadequate treatment (not completing the full course or not taking the correct dose), reinfection from an untreated partner, or in rare cases, the parasite having developed resistance to metronidazole. The high rate of reinfection despite the possibility of a cure indicates challenges in partner notification and adherence to treatment and abstinence guidelines. Simultaneous partner management and abstinence from sexual intercourse until both parties have completed treatment and are symptom-free is crucial to break the chain of transmission and achieve long-term treatment effectiveness.<\/span><\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"8_Co-infection_and_Differential_Diagnosis\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"174\">8. Co-infection and Differential Diagnosis<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"81_Co-infection_with_other_STI_Agents\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"175\">8.1. Co-infection with other STI Agents<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"176\">Co-infection with other urogenital pathogens is very common in individuals with Trichomoniasis. A Trichomoniasis diagnosis should trigger a broader STI screening, as the presence of one STI is an indicator of an increased risk for other diseases. Commonly co-infecting pathogens include\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"177\">Chlamydia trachomatis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"178\">,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"179\">Neisseria gonorrhoeae<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"180\">,\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"181\">Treponema pallidum<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"182\">\u00a0(syphilis), human papillomavirus (HPV), and herpes simplex virus (HSV) types 1 and 2. Specifically, women with bacterial vaginosis (BV) are highly likely to be co-infected with\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"183\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"184\">\u00a0(co-infection rate of 60-80%) and\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"185\">Candida<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"186\">\u00a0spp. (20-30%). Due to the high co-infection rate, if\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"187\">T. vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"188\">\u00a0or abnormal vaginal discharge is present, testing for other STIs like HIV and syphilis is recommended. All women with BV should also be tested for HIV and other STIs. The high rate of co-infection requires a &#8220;syndromic approach&#8221; or comprehensive STI panel testing when Trichomoniasis is suspected or diagnosed. Healthcare providers should adopt a holistic screening approach, especially in high-risk populations, to effectively manage STIs and prevent further transmission and complications.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"82_Which_Agents_are_Trichomoniasis_Symptoms_Easily_Confused_With\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"189\">8.2. Which Agents are Trichomoniasis Symptoms Easily Confused With?<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"190\">Sexually transmitted diseases (STIs) such as Chlamydia, Gonorrhea, and Trichomoniasis often have similar symptoms like abnormal discharge, painful urination, or itching, making differential diagnosis difficult if relying only on symptoms. This emphasizes the need for professional medical diagnosis through testing. Below is a comparison of Trichomoniasis symptoms with some other common intimate area conditions:\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"191\">(Note: The detailed comparison table was provided in a previous response.)<\/span><\/i><\/p>\n<p style=\"text-align: center;\">Table 2: Differentiating Symptoms between Trichomoniasis and Common Intimate Area Conditions<\/p>\n<table style=\"width: 1350px;\">\n<thead>\n<tr>\n<th style=\"width: 158px;\">Condition<\/th>\n<th style=\"width: 801px;\">Common Symptoms (Discharge, Odor, Itching\/Pain)<\/th>\n<th style=\"width: 391px;\">Differentiating Features\u00a0<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"width: 158px; text-align: left;\"><strong><span data-ast-node-id=\"32\">Trichomoniasis<\/span><\/strong><\/td>\n<td style=\"width: 801px; text-align: left;\"><span data-ast-node-id=\"33\">Green or yellow, frothy discharge; foul, fishy odor; vaginal pain or burning; inflammation; itching\/irritation inside the penis; burning after urination\/ejaculation; penile discharge\u00a0<\/span><\/td>\n<td style=\"width: 391px; text-align: left;\"><span data-ast-node-id=\"34\">&#8220;Strawberry cervix&#8221; (rare)\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 158px; text-align: left;\"><strong><span data-ast-node-id=\"35\">Bacterial Vaginosis (BV)<\/span><\/strong><\/td>\n<td style=\"width: 801px; text-align: left;\"><span data-ast-node-id=\"36\">Thin, homogeneous discharge; fishy odor that may worsen after intercourse; possible pelvic discomfort\u00a0<\/span><\/td>\n<td style=\"width: 391px; text-align: left;\"><span data-ast-node-id=\"37\">Often\u00a0<\/span><i><span data-ast-node-id=\"38\">no clear inflammation<\/span><\/i><span data-ast-node-id=\"39\">; positive Whiff test (fishy odor upon adding KOH)<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 158px; text-align: left;\"><strong><span data-ast-node-id=\"42\">Yeast Infection (Vulvovaginal Candidiasis)<\/span><\/strong><\/td>\n<td style=\"width: 801px; text-align: left;\"><span data-ast-node-id=\"43\">White, thick, cottage cheese-like discharge; vulvar itching or burning\u00a0<\/span><\/td>\n<td style=\"width: 391px; text-align: left;\"><span data-ast-node-id=\"44\">Usually\u00a0<\/span><i><span data-ast-node-id=\"45\">no foul odor<\/span><\/i><span data-ast-node-id=\"46\">\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 158px; text-align: left;\"><strong><span data-ast-node-id=\"49\">Chlamydia<\/span><\/strong><\/td>\n<td style=\"width: 801px; text-align: left;\"><span data-ast-node-id=\"50\">Often few or no symptoms. If present: painful urination, lower abdominal pain, lower back pain, fever, vaginal\/penile discharge, vaginal pain during intercourse, bleeding between periods, testicular pain\/swelling, rectal pain\/bleeding\/discharge\u00a0<\/span><\/td>\n<td style=\"width: 391px; text-align: left;\"><span data-ast-node-id=\"51\">More likely to cause testicular pain in men and bleeding between periods in women than Trichomoniasis\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 158px; text-align: left;\"><strong><span data-ast-node-id=\"52\">Gonorrhea\u00a0<\/span><\/strong><\/td>\n<td style=\"width: 801px; text-align: left;\"><span data-ast-node-id=\"53\">Often few or no symptoms. If present: thick, cloudy or bloody discharge from the penis\/vagina; painful urination; heavy menstrual bleeding or bleeding between periods; painful, swollen testicles; painful bowel movements; anal itching; rectal discharge\/pain\/bleeding\u00a0<\/span><\/td>\n<td style=\"width: 391px; text-align: left;\"><span data-ast-node-id=\"54\">More likely to cause testicular pain in men and bleeding between periods in women than Trichomoniasis\u00a0<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: center;\">\u00a0<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"9_Conclusion\"><\/span><strong><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"192\">9. Conclusion<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align: justify;\"><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"193\">Trichomoniasis, caused by the parasite\u00a0<\/span><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"194\">Trichomonas vaginalis<\/span><\/i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"195\">, is the most common non-viral sexually transmitted infection globally. Although curable, the high prevalence and large number of asymptomatic cases have created significant challenges in controlling the disease. The high asymptomatic rate (about 70%) means many people are unaware they are infected and unintentionally transmit the disease, making symptom-based diagnosis unreliable and hindering prevention efforts. The disease can cause many serious consequences for reproductive health in both men and women, including vaginitis, cervicitis, pelvic inflammatory disease, and infertility. Notably, for pregnant women, Trichomoniasis is associated with adverse pregnancy outcomes like preterm birth, low birth weight, and premature rupture of membranes. Furthermore, Trichomoniasis infection significantly increases the risk of acquiring and transmitting HIV by causing genital inflammation, creating a favorable condition for the HIV virus to enter. The potential link with cervical cancer (especially when co-infected with HPV) and prostate cancer is also a critical aspect of this disease. Accurate diagnosis of Trichomoniasis requires laboratory testing, with Nucleic Acid Amplification Tests (NAATs) currently considered the gold standard due to their high sensitivity and specificity. Treatment with metronidazole or tinidazole is effective, but adherence to the treatment regimen and simultaneous treatment of all partners is necessary to prevent reinfection, a common problem due to untreated partners. For prevention, safe sexual practices such as maintaining monogamy, correct condom use, and limiting the number of partners are crucial. However, it should be noted that condoms may not provide complete protection due to the potential for transmission through skin-to-skin contact in uncovered areas. Regular screening, especially in high-risk groups such as women with HIV or those with multiple partners, along with open sexual health counseling, are essential strategies for controlling the spread of the disease. The high rate of co-infection with other STIs also emphasizes the need for comprehensive screening when Trichomoniasis is diagnosed. Overall, raising community awareness about Trichomoniasis, improving access to advanced diagnostic and treatment methods, along with implementing comprehensive prevention strategies and effective partner management, are crucial steps to reduce the burden of this common yet often neglected disease.<\/span><\/p>\n<p><em style=\"font-size: 16px;\"><i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"215\">This article is written by<\/span><\/i> <a href=\"https:\/\/gdhealth.vn\/doi-ngu\/bac-si-do-huu-dat\/\"><b>Dr \u0110\u1ed7 H\u1eefu \u0110\u1ea1t.<\/b><\/a> <i><span class=\"appsElementsGenerativeaiAstAnimated\" data-ast-node-id=\"217\">The doctor has many years of in-depth experience in reproductive and sexual health care.<\/span><\/i><\/em><\/p>\n<h4 style=\"text-align: justify;\"><em><b>Reference<\/b><\/em><\/h4>\n<p><span style=\"font-weight: 400;\">[1]. Trichomoniasis &#8211; CDC Fact Sheet. &#8211; DPBH, <a href=\"https:\/\/dpbh.nv.gov\/uploadedFiles\/dpbh.nv.gov\/content\/Programs\/STD\/dta\/Publications\/Trichomoniasis.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/dpbh.nv.gov\/uploadedFiles\/dpbh.nv.gov\/content\/Programs\/STD\/dta\/Publications\/Trichomoniasis.pdf\u00a0<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">[2]. Trichomoniasis &#8211; Symptoms &amp; causes &#8211; Mayo Clinic, <\/span><a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/trichomoniasis\/symptoms-causes\/syc-20378609\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.mayoclinic.org\/diseases-conditions\/trichomoniasis\/symptoms-causes\/syc-20378609<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[3]. Trichomoniasis &#8211; World Health Organization (WHO), <\/span><a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trichomoniasis\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trichomoniasis<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[4]. Trichomoniasis: Causes, Symptoms, Testing &amp; Treatment &#8211; Cleveland Clinic, <\/span><a href=\"https:\/\/my.clevelandclinic.org\/health\/diseases\/4696-trichomoniasis\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/my.clevelandclinic.org\/health\/diseases\/4696-trichomoniasis<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[5]. Trichomoniasis: Symptoms, Causes, and Treatment, &#8211; WebMD, <\/span><a href=\"https:\/\/www.webmd.com\/sexual-conditions\/trichomoniasis\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.webmd.com\/sexual-conditions\/trichomoniasis<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[6]. Trichomoniasis &#8211; PMC, <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10713349\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10713349\/<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[7]. About Trichomoniasis &#8211; CDC, <\/span><a href=\"https:\/\/www.cdc.gov\/trichomoniasis\/about\/index.html\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.cdc.gov\/trichomoniasis\/about\/index.html<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[8]. The Past, Present, and Future in the Diagnosis of a Neglected Sexually Transmitted Infection: Trichomoniasis &#8211; MDPI, <\/span><a href=\"https:\/\/www.mdpi.com\/2076-0817\/13\/2\/126\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.mdpi.com\/2076-0817\/13\/2\/126<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[9]. Brasil &#8211; Factors associated with Trichomonas &lt;i&gt;vaginalis &#8230; &#8211; SciELO, <\/span><a href=\"https:\/\/www.scielo.br\/j\/bjid\/a\/GGk5X4PZDMCHkMtb8zS4rvy\/?lang=en\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.scielo.br\/j\/bjid\/a\/GGk5X4PZDMCHkMtb8zS4rvy\/?lang=en<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[10]. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines &#8211; PMC &#8211; National Institutes of Health (NIH) |, <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9006969\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9006969\/<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[11]. 2018 European (IUSTI\/WHO) International Union against sexually &#8230;, <\/span><a href=\"https:\/\/iusti.org\/wp-content\/uploads\/2019\/12\/Vagdx2018.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/iusti.org\/wp-content\/uploads\/2019\/12\/Vagdx2018.pdf<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[12]. Trichomoniasis &#8211; StatPearls &#8211; NCBI Bookshelf, <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534826\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534826\/<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[13]. Vaginitis &#8211; Bacterial Vaginosis, Vulvovaginal Candidiasis, and Trichomoniasis | Choose the Right Test &#8211; ARUP Consult, <\/span><a href=\"https:\/\/arupconsult.com\/content\/vaginitis-bacterial-vaginosis-vulvovaginal-candidiasis-and-trichomoniasis\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/arupconsult.com\/content\/vaginitis-bacterial-vaginosis-vulvovaginal-candidiasis-and-trichomoniasis<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[14]. Trichomonas vaginalis infection-associated risk of cervical cancer: A &#8230;, <\/span><a href=\"https:\/\/www.researchgate.net\/publication\/325863559_Trichomonas_vaginalis_infection-associated_risk_of_cervical_cancer_A_meta-analysis\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.researchgate.net\/publication\/325863559_Trichomonas_vaginalis_infection-associated_risk_of_cervical_cancer_A_meta-analysis<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[15]. Trichomoniasis &#8211; STI Treatment Guidelines &#8211; CDC, <\/span><a href=\"https:\/\/www.cdc.gov\/std\/treatment-guidelines\/trichomoniasis.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.cdc.gov\/std\/treatment-guidelines\/trichomoniasis.htm<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[16]. Persistent Trichomoniasis in Pregnancy: A Case Report Calling for Further Research to Alternative Antibiotic Treatment &#8211; PMC, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12001296\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12001296\/<\/a>. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">[17]. Vaginal Microbiota of the Sexually Transmitted Infections Caused by Chlamydia trachomatis and Trichomonas vaginalis in Women with Vaginitis in Taiwan &#8211; PMC, <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8470505\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8470505\/<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[18]. Trichomoniasis Test: MedlinePlus Medical Test, <\/span><a href=\"https:\/\/medlineplus.gov\/lab-tests\/trichomoniasis-test\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/medlineplus.gov\/lab-tests\/trichomoniasis-test\/<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[19]. Advances in Laboratory Detection of Trichomonas vaginalis &#8211; APHL, <\/span><a href=\"https:\/\/www.aphl.org\/aboutAPHL\/publications\/Documents\/ID_2013August_Advances-in-Laboratory-Detection-of-Trichomonas-vaginalis.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.aphl.org\/aboutAPHL\/publications\/Documents\/ID_2013August_Advances-in-Laboratory-Detection-of-Trichomonas-vaginalis.pdf<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[20]. Update on Guidelines and Technology in the Diagnosis and Treatment of Trichomonas vaginalis, <\/span><a href=\"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/obg_reachmd_0416_0.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/cdn.mdedge.com\/files\/s3fs-public\/obg_reachmd_0416_0.pdf<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[21]. Trichomoniasis Testing, <\/span><a href=\"https:\/\/www.testing.com\/tests\/trichomoniasis-testing\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.testing.com\/tests\/trichomoniasis-testing\/<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[22]. Trichomonas vaginalis by NAAT &#8211; MU Health Care Laboratory Test Catalog, <\/span><a href=\"https:\/\/muhealth.testcatalog.org\/show\/Trich-by-NAAT\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/muhealth.testcatalog.org\/show\/Trich-by-NAAT<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[23]. Bacterial Vaginosis &#8211; STI Treatment Guidelines &#8211; CDC, <\/span><a href=\"https:\/\/www.cdc.gov\/std\/treatment-guidelines\/bv.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.cdc.gov\/std\/treatment-guidelines\/bv.htm<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[24]. What is the recommended treatment for Trichomonas vaginalis? &#8211; Dr.Oracle AI, <\/span><a href=\"https:\/\/www.droracle.ai\/articles\/204000\/treatment-guideline-for-trichomonas-vaginalis\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.droracle.ai\/articles\/204000\/treatment-guideline-for-trichomonas-vaginalis<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[25]. Trichomoniasis &#8211; 2015 STD Treatment Guidelines, <\/span><a href=\"http:\/\/medbox.iiab.me\/modules\/en-cdc\/www.cdc.gov\/std\/tg2015\/trichomoniasis.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">http:\/\/medbox.iiab.me\/modules\/en-cdc\/www.cdc.gov\/std\/tg2015\/trichomoniasis.htm<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[26]. Updated CDC guidelines: Diagnosing and treating STIs &#8211; Contemporary OB\/GYN, <\/span><a href=\"https:\/\/www.contemporaryobgyn.net\/view\/updated-cdc-guidelines-on-treating-sexually-transmitted-infections\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.contemporaryobgyn.net\/view\/updated-cdc-guidelines-on-treating-sexually-transmitted-infections<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[27]. Summary of CDC STI Treatment Guidelines, 2021, <\/span><a href=\"https:\/\/www.cdc.gov\/std\/treatment-guidelines\/wall-chart.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.cdc.gov\/std\/treatment-guidelines\/wall-chart.pdf<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[28]. Trichomoniasis &#8211; Diagnosis &amp; treatment &#8211; Mayo Clinic, <\/span><a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/trichomoniasis\/diagnosis-treatment\/drc-20378613\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.mayoclinic.org\/diseases-conditions\/trichomoniasis\/diagnosis-treatment\/drc-20378613<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[29]. Parasites &#8211; Trichomonas vaginalis Susceptibility Testing &#8211; CDC, <\/span><a href=\"https:\/\/www.cdc.gov\/parasites\/resources\/Trichomonas_vaginalis.html\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.cdc.gov\/parasites\/resources\/Trichomonas_vaginalis.html<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[30]. Trichomoniasis &#8211; CDC stacks, <\/span><a href=\"https:\/\/stacks.cdc.gov\/view\/cdc\/165381\/cdc_165381_DS1.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/stacks.cdc.gov\/view\/cdc\/165381\/cdc_165381_DS1.pdf<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[31]. Sexually Transmitted Diseases Treatment Guidelines, 2015 &#8211; CDC, <\/span><a href=\"https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6403a1.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6403a1.htm<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[32]. Retesting After Treatment to Detect Repeat Infections &#8211; CDC, <\/span><a href=\"https:\/\/www.cdc.gov\/std\/treatment-guidelines\/clinical-retesting.htm\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.cdc.gov\/std\/treatment-guidelines\/clinical-retesting.htm<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">[33]. Chlamydia vs Gonorrhea vs Trichomoniasis | Call-On-Doc &#8211; CallonDoc, <a href=\"https:\/\/www.callondoc.com\/en\/blogs\/chlamydia-vs-gonorrhea-vs-trichomoniasis\" target=\"_blank\" rel=\"noopener\">https:\/\/www.callondoc.com\/en\/blogs\/chlamydia-vs-gonorrhea-vs-trichomoniasis<\/a><\/span><\/p>\n<p>[34]. 188052: Trichomonas vaginalis, NAA &#8211; Labcorp, <a href=\"https:\/\/www.labcorp.com\/tests\/188052\/trichomonas-vaginalis-naa\" target=\"_blank\" rel=\"noopener\">https:\/\/www.labcorp.com\/tests\/188052\/trichomonas-vaginalis-naa<\/a><\/p>\n<p>[35]. Yeast infection (vaginal) &#8211; Symptoms and causes &#8211; Mayo Clinic, <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/yeast-infection\/symptoms-causes\/syc-20378999\" target=\"_blank\" rel=\"noopener\">https:\/\/www.mayoclinic.org\/diseases-conditions\/yeast-infection\/symptoms-causes\/syc-20378999<\/a><\/p>\n<p>[36]. CDC Updates Trichomoniasis Treatment Guidelines | Clinician.com, <a href=\"https:\/\/www.clinician.com\/articles\/149429-cdc-updates-trichomoniasis-treatment-guidelines\" target=\"_blank\" rel=\"noopener\">https:\/\/www.clinician.com\/articles\/149429-cdc-updates-trichomoniasis-treatment-guidelines<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>1. Introduction to Trichomoniasis 1.1. What is\u00a0Trichomonas vaginalis? Trichomoniasis is a very common sexually transmitted infection (STI), caused by a single-celled protozoan parasite named\u00a0Trichomonas vaginalis. It is important to note that Trichomoniasis is caused by a parasite, not a virus. It is the most common non-viral STI globally and can be completely cured with medication. [&hellip;]<\/p>\n","protected":false},"author":49,"featured_media":2744,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[139],"tags":[],"class_list":["post-5086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-bulletin"],"acf":[],"_links":{"self":[{"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/posts\/5086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/users\/49"}],"replies":[{"embeddable":true,"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/comments?post=5086"}],"version-history":[{"count":2,"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/posts\/5086\/revisions"}],"predecessor-version":[{"id":5088,"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/posts\/5086\/revisions\/5088"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/media\/2744"}],"wp:attachment":[{"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/media?parent=5086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/categories?post=5086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gdhealth.vn\/en\/wp-json\/wp\/v2\/tags?post=5086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}